Short Communication Light and Electron Microscopic Localization of ,B-amyloid Protein in Muscle Biopsies of Patients with Inclusion-body Myositis

In 11 of 11 inclusion-body myositis (IBM) patients, including one hereditary case, vacuolated muscle fibers contained large and multiple small inclusions immunoreactive for 0-amyloid protein (PAP). All IBM muscle biopsies had characteristic cytoplasmic tubulo-filaments (CTFs) by electron microscopy. None of 14 control muscle biopsies contained the PAP immunoreactive (IR) inclusions characteristic of IBM. On the light microscopy level rAP-IR inclusions colocalized with ubiquitin immunoreactivity. By immunogold electronmicroscopy, f3AP immunoreactivity was localized to a) amorphous, poorly defined structures, b) dense floccular material c) clusters of loosely packed amyloidlike fibrils 6-8 nm in diameter, and d) poorly defined loose fibrillar structures 6-8 nm in diameter. PAP immunoreactive structures were often in proximity to CTFs, but CTFs themselves never contained f3AP-IR Our study pro-vides the first demonstration of f3AP accumulations in abnormal human muscle. This finding suggests that in addition to Alzbeimer's disease, Down syndrome, and Dutch-type hereditary cerebrovascular amyloidosis, P3AP may play an important role in the pathogenesis of other diseases, including ones outside the central nervous system, for example, IBM. (Am JPathol 1992, 141:31-36) arms, male predominance, and often a poor or no to immunosuppression

[1]  J Carter,et al.  Molecular Pathology of Alzheimer's Disease , 2013 .

[2]  W. Engel,et al.  Immunocytochemical localization of ubiquitin at human neuromuscular junctions , 1992, Neuropathology and applied neurobiology.

[3]  W. Engel,et al.  Immunocytochemical localization of ubiquitin in inclusion body myositis allows its light‐microscopic distinction from polymyositis , 1992, Neurology.

[4]  J. Mendell,et al.  Amyloid filaments in inclusion body myositis. Novel findings provide insight into nature of filaments. , 1991, Archives of neurology.

[5]  M. Dalakas Polymyositis, dermatomyositis and inclusion-body myositis. , 1991, The New England journal of medicine.

[6]  W. Engel,et al.  Immunolocalization of ubiquitin in muscle biopsies of patients with inclusion body myositis and oculopharyngeal muscular dystrophy , 1991, Neuroscience Letters.

[7]  E. Shoubridge,et al.  Familial inclusion body myositis among Kurdish-Iranian Jews. , 1991, Archives of neurology.

[8]  G. Perry,et al.  Ultrastructural localization of beta-amyloid, tau, and ubiquitin epitopes in extracellular neurofibrillary tangles. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[9]  W. Engel,et al.  Immunocytochemical localization of desmin at human neuromuscular junctions , 1990, Neurology.

[10]  J. Trojanowski,et al.  Defined neurofilament, tau, and beta-amyloid precursor protein epitopes distinguish Alzheimer from non-Alzheimer senile plaques. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[11]  D. Dickson,et al.  Modified Bielschowsky and Immunocytochemical Studies on Cerebellar Plaques in Alzheimer's Disease , 1990, Journal of neuropathology and experimental neurology.

[12]  D. Selkoe Molecular pathology of amyloidogenic proteins and the role of vascular amyloidosis in Alzheimer's disease , 1989, Neurobiology of Aging.

[13]  W J Litchy,et al.  Inclusion body myositis. Observations in 40 patients. , 1989, Brain : a journal of neurology.

[14]  F. Tagliavini,et al.  Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals , 1988, Neuroscience Letters.

[15]  V. Chau,et al.  Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[16]  K. Grzeschik,et al.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.

[17]  D. Selkoe,et al.  Isolation of Low‐Molecular‐Weight Proteins from Amyloid Plaque Fibers in Alzheimer's Disease , 1986, Journal of neurochemistry.

[18]  G. Glenner,et al.  Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[19]  C. Masters,et al.  Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S M Chou,et al.  Myxovirus-Like Structures in a Case of Human Chronic Polymyositis , 1967, Science.

[21]  W. Engel Muscle biopsies in neuromuscular diseases. , 1967, Pediatric clinics of North America.

[22]  E. Lieb Permanent stain for amyloid. , 1947, American journal of clinical pathology.

[23]  S. Hirai,et al.  Diffuse type of senile plaques in the brains of Alzheimer-type dementia , 1988, Acta Neuropathologica.

[24]  Richard J. Barohn,et al.  Inclusion body myositis , 2000, Current treatment options in neurology.

[25]  G. Glenner,et al.  Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. , 1984, Biochemical and biophysical research communications.